Abstract
Purpose of Review
Although rare, breast angiosarcoma imparts poor outcomes relative to other breast malignancies. Here, we review the current literature focusing on radiation-induced angiosarcoma of the breast (RIA), a subset of secondary breast angiosarcoma.
Recent Findings
The risk of developing RIA increases with time after radiation therapy, and incidence is expected to increase. Cross-sectional imaging with MRI or CT has a higher sensitivity for RIA detection than ultrasound and mammography studies. The clinical outcomes of RIA are improving with the use of wide resections and systemic chemotherapy, with up to an 85% 5-year overall survival in surgically resected patients. Multidisciplinary team engagement improves access to emerging therapies and correlates with increased survival.
Summary
Improvements in diagnostic techniques, multidisciplinary care, and inclusion of modern systemic therapies in treatment of RIA may be responsible for improved survival. Future studies focusing on systemic treatment and access to sarcoma expertise may play a further impact survival for this rare disease.

Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Yap J, Chuba PJ, Thomas R, et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(5):1231–7.
Conti M, Morciano F, Rossati C, Gori E, Belli P, Fornasa F, Romanucci G, Rella R. Angiosarcoma of the breast: overview of current data and multimodal imaging findings. J Imaging. 2023;9(5):94.
Bentley H, Roberts J, Hayes M, et al. The role of imaging in the diagnosis of primary and secondary breast angiosarcoma: twenty-five-year experience of a provincial cancer institution. Clin Breast Cancer. 2023;23(2):e45–53.
Verdin V, Mattart L, Cusumano PG, et al. Angiosarcoma associated with radiation therapy after treatment of breast cancer. Retrospective study on ten years. Cancer Radiother. 2021;25(2):114–8.
• Friedrich AU, Reisenbichler ES, Heller DR, et al. Characteristics and long-term risk of breast angiosarcoma. Ann Surg Oncol. 2021;28(9):5112–8. Friedrich et al. reports a large study utilizing the Surveillance, Epidemiology, and End Results (SEER) database examining risk factors associated with the development of radiation induced angiosarcoma.
Bryant AK, Banegas MP, Martinez ME, Mell LK, Murphy JD. Trends in radiation therapy among cancer survivors in the United States, 2000–2030. Cancer Epidemiol Biomarkers Prev. 2017;26(6):963–70.
de Boniface J, Szulkin R, Johansson ALV. Survival after breast conservation vs mastectomy adjusted for comorbidity and socioeconomic status: a Swedish national 6-year follow-up of 48 986 women. JAMA Surg. 2021;156(7):628–37.
Alves I, Marques JC. Radiation-induced angiosarcoma of the breast: a retrospective analysis of 15 years’ experience at an oncology center. Radiol Bras. 2018;51(5):281–6.
Mito JK, Mitra D, Barysauskas CM, et al. A comparison of outcomes and prognostic features for radiation-associated angiosarcoma of the breast and other radiation-associated sarcomas. Int J Radiat Oncol Biol Phys. 2019;104(2):425–35.
Rombouts AJM, Huising J, Hugen N, et al. Assessment of radiotherapy-associated angiosarcoma after breast cancer treatment in a Dutch population-based study. JAMA Oncol. 2019;5(2):267–9.
Gutkin PM, Ganjoo KN, Lohman M, et al. Angiosarcoma of the breast: management and outcomes. Am J Clin Oncol. 2020;43(11):820–5.
Rummel KA, Gao RW, Francis LN, Petersen IA, Mutter RW, Corbin KS. Secondary breast angiosarcoma following accelerated partial breast irradiation with intracavitary multicatheter applicator brachytherapy. Brachytherapy. 2023;22(4):487–90.
Takehara Y, Matsuda N, Kobayashi D, et al. Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population. Breast Cancer. 2023;30(5):739–47.
Banks J, George J, Potter S, et al. Breast Angiosarcoma Surveillance Study: UK national audit of management and outcomes of angiosarcoma of the breast and chest wall. Br J Surg. 2021;108(4):388–94.
Yan M, Gilmore H, Bomeisl P, Harbhajanka A. Clinicopathologic and immunohistochemical study of breast angiosarcoma. Ann Diagn Pathol. 2021;54: 151795.
Li GZ, Fairweather M, Wang J, Orgill DP, Bertagnolli MM, Raut CP. Cutaneous radiation-associated breast angiosarcoma: radicality of surgery impacts survival. Ann Surg. 2017;265(4):814–20.
Brenn T, Fletcher CD. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases. Am J Surg Pathol. 2005;29(8):983–96.
Salminen SH, Sampo MM, Bohling TO, et al. Radiation-associated angiosarcoma of the breast: analysis of diagnostic tools in a registry-based population. Acta Radiol. 2022;63(1):22–7.
Taffurelli M, Pellegrini A, Meattini I, et al. Secondary breast angiosarcoma: a multicentre retrospective survey by the National Italian Association of Breast Surgeons (ANISC). Breast. 2019;45:56–60.
Cannella L, Perri F, Clemente O, et al. The complex management of the breast angiosarcoma: a retrospective study. Oncology. 2023;101(4):234–9.
Salminen SH, Sampo MM, Bohling TO, Tuomikoski L, Tarkkanen M, Blomqvist CP. Radiation-associated sarcoma after breast cancer in a nationwide population: increasing risk of angiosarcoma. Cancer Med. 2018;7(9):4825–35.
Notter M, Stutz E, Thomsen AR, Vaupel P. Radiation-associated angiosarcoma ofthe breast and chest wall treated with thermography-controlled, contactless wira-hyperthermia and hypofractionated re-irradiation. Cancers (Basel). 2021;13(15):3911.
Cohen-Hallaleh RB, Smith HG, Smith RC, et al. Radiation induced angiosarcoma of the breast: outcomes from a retrospective case series. Clin Sarcoma Res. 2017;7:15.
•• Guram S, Covelli AM, O’Neill AC, et al. Multidisciplinary intervention in radiation-associated angiosarcoma of the breast: patterns of recurrence and response to treatment. Ann Surg Oncol. 2022;29(1):522–32. Guram et al. highlights prognostic factors associated with prolonged survival in RIA patients. The authors report survival outcomes for a cohort of patients receiving neoadjuvant chemotherapy, and emphasize the importance of multidisciplinary team involvement in the management of RIA.
• Salminen SH, Wiklund T, Sampo MM, et al. Treatment and prognosis of radiation-associated breast angiosarcoma in a nationwide population. Ann Surg Oncol. 2020;27(4):1002–10. Salminen et al report outcomes from their Finnish Cancer Database which details management strategies and outcomes of their cohort of patients with RIA, and includes prognostic factors for survival.
Kacen MG, Sangle N, Kornecki A. Contrast-enhanced mammography in the diagnosis of breast angiosarcoma. Case Rep Radiol. 2021;2021:5542786.
Cassou-Mounat T, Champion L, Bozec L, et al. Primary and secondary breast angiosarcoma: FDG PET/CT series. Clin Nucl Med. 2019;44(1):e33–5.
Shah S, Rosa M. Radiation-associated angiosarcoma of the breast: clinical and pathologic features. Arch Pathol Lab Med. 2016;140(5):477–81.
Daniels BH, Ko JS, Rowe JJ, Downs-Kelly E, Billings SD. Radiation-associated angiosarcoma in the setting of breast cancer mimicking radiation dermatitis: a diagnostic pitfall. J Cutan Pathol. 2017;44(5):456–61.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Soft Tissue Sarcoma (Version 2.2023). 2023. https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf. Accessed 11 Oct 2023.
Reijers SJM, HuisInt Veld EA, Grunhagen DJ, et al. Prognosis of patients with cutaneous angiosarcoma after surgical resection with curative intent: is there a difference between the subtypes? Ann Surg Oncol. 2023;30(1):493–502.
Kronenfeld JP, Crystal JS, Ryon EL, Yadegarynia S, Chitters C, Yechieli R, D’Amato G, Rosenberg AE, Kesmodel SB, Trent JC, Goel N. Clinical outcomes for primary and radiation-associated angiosarcoma of the breast with multimodal treatment: long-term survival Is achievable. Cancers (Basel). 2021;13(15):3814.
Herb J, Maduekwe UN, Goel N, Rosenberger LH, Spanheimer PM. Does angiosarcoma of the breast need nodal staging? J Am Coll Surg. 2022;234(5):774–82.
Kokkali S, Moreno JD, Klijanienko J, Theocharis S. Clinical and molecular insights of radiation-induced breast sarcomas: is there hope on the horizon for effective treatment of this aggressive disease? Int J Mol Sci. 2022;23(8):4125.
Florou V, Rosenberg AE, Wieder E, et al. Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution. J Immunother Cancer. 2019;7(1):213.
Depla AL, Scharloo-Karels CH, de Jong MAA, et al. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J Cancer. 2014;50(10):1779–88.
Yin M, Wang W, Drabick JJ, Harold HA. Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study. BMC Cancer. 2017;17(1):295.
Hodgson NC, Bowen-Wells C, Moffat F, Franceschi D, Avisar E. Angiosarcomas of the breast: a review of 70 cases. Am J Clin Oncol. 2007;30(6):570–3.
Teng L, Yan S, Du J, Yang R, Xu P, Tao W. Clinicopathological analysis and prognostic treatment study of angiosarcoma of the breast: a SEER population-based analysis. World J Surg Oncol. 2023;21(1):144.
Author information
Authors and Affiliations
Contributions
K.J. and J.G. wrote the manuscript text. K.J. prepared the figures. K.J. and J.G. reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jackson, K.M., Grumley, J.G. Radiation-Induced Breast Angiosarcoma: Updates on a Rare Disease. Curr Breast Cancer Rep 16, 177–184 (2024). https://doi.org/10.1007/s12609-024-00542-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12609-024-00542-5